miR-150 Promotes Human Breast Cancer Growth and Malignant Behavior by Targeting the Pro-Apoptotic Purinergic P2X7 Receptor

The P2X7 receptor regulates cell growth through mediation of apoptosis. Low level expression of P2X7 has been linked to cancer development because tumor cells harboring a defective P2X7 mechanism can escape P2X7 pro-apoptotic control. microRNAs (miRNAs) function as negative regulators of post-transcriptional gene expression, playing major roles in cellular differentiation, proliferation, and metastasis. In this study, we found that miR-150 was over-expressed in breast cancer cell lines and tissues. In these breast cancer cell lines, blocking the action of miR-150 with inhibitors leads to cell death, while ectopic expression of the miR-150 results in increased cell proliferation. We deploy a microRNA sponge strategy to inhibit miR-150 in vitro, and the result demonstrates that the 3′-untranslated region (3′UTR) of P2X7 receptor contains a highly conserved miR-150-binding motif and its direct interaction with miR-150 down-regulates endogenous P2X7 protein levels. Furthermore, our findings demonstrate that miR-150 over-expression promotes growth, clonogenicity and reduces apoptosis in breast cancer cells. Meanwhile, these findings can be decapitated in nude mice with breast cancer xenografts. Finally, these observations strengthen our working hypothesis that up-regulation of miR-150 in breast cancer is inversely associated with P2X7 receptor expression level. Together, these findings establish miR-150 as a novel regulator of P2X7 and a potential therapeutic target for breast cancer.

[1]  G. MacLennan,et al.  P2X7 receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin , 2009, Purinergic Signalling.

[2]  Sumit Arora,et al.  MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. , 2011, Carcinogenesis.

[3]  M. Gavala,et al.  Mutation of putative N-linked glycosylation sites on the human nucleotide receptor P2X7 reveals a key residue important for receptor function. , 2010, Biochemistry.

[4]  J. Li,et al.  MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1 , 2012, Oncogene.

[5]  Yang Wang,et al.  Regulation of lung surfactant secretion by microRNA-150. , 2012, Biochemical and biophysical research communications.

[6]  J. Egido,et al.  Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. , 1999, Atherosclerosis.

[7]  S. Layé,et al.  Impaired Interleukin-1β and c-Fos Expression in the Hippocampus Is Associated with a Spatial Memory Deficit in P2X7 Receptor-Deficient Mice , 2009, PloS one.

[8]  F. Di Virgilio,et al.  P2X7: a growth-promoting receptor—implications for cancer , 2009, Purinergic Signalling.

[9]  F. Abdul-Karim,et al.  The P2X7 Receptor: A Novel Biomarker of Uterine Epithelial Cancers , 2006, Cancer Epidemiology Biomarkers & Prevention.

[10]  J. Potashkin,et al.  Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. , 2007, Gynecologic oncology.

[11]  B. Zhivotovsky,et al.  Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. , 2006, Current pharmaceutical design.

[12]  Haihua Gu,et al.  Abstract P5-10-06: A functional role for miR-150 in breast cancer , 2012 .

[13]  T. Prolla,et al.  Mitochondrial DNA mutations and apoptosis in mammalian aging. , 2006, Cancer research.

[14]  I. Chessell,et al.  The role of P2X7 in pain and inflammation , 2007, Purinergic Signalling.

[15]  H. Tagawa,et al.  The role of microRNA-150 as a tumor suppressor in malignant lymphoma , 2011, Leukemia.

[16]  Chang Gong,et al.  Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer* , 2011, The Journal of Biological Chemistry.

[17]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[18]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[19]  L. Luo,et al.  Regulation of P2X7 gene transcription , 2009, Purinergic Signalling.

[20]  Robert A. Weinberg,et al.  Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.

[21]  Shangqin Guo,et al.  MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. , 2008, Developmental cell.

[22]  Péter Csermely,et al.  Apoptosis, necrosis and cellular senescence: chaperone occupancy as a potential switch , 2003, Aging cell.

[23]  Kai Li,et al.  MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. , 2010, Biochemical and biophysical research communications.

[24]  A. Armugam,et al.  MicroRNAs as therapeutic targets in human diseases , 2007, Expert opinion on therapeutic targets.

[25]  Christopher S. Stevenson,et al.  P2X7 Receptor and Caspase 1 Activation Are Central to Airway Inflammation Observed after Exposure to Tobacco Smoke , 2011, PloS one.

[26]  A. van den Berg,et al.  miRNA analysis in B‐cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR‐150 and high BIC/miR‐155 expression , 2008, The Journal of pathology.

[27]  Carlos Agustí,et al.  MicroRNAs Expressed during Lung Cancer Development Are Expressed in Human Pseudoglandular Lung Embryogenesis , 2009, Oncology.

[28]  J. Potashkin,et al.  MicroRNAs miR-186 and miR-150 Down-regulate Expression of the Pro-apoptotic Purinergic P2X7 Receptor by Activation of Instability Sites at the 3′-Untranslated Region of the Gene That Decrease Steady-state Levels of the Transcript* , 2008, Journal of Biological Chemistry.

[29]  Debmalya Barh,et al.  Let-7, miR-125, miR-205, and miR-296 are prospective therapeutic agents in breast cancer molecular medicine , 2008 .

[30]  Ha Won Kim,et al.  microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4 , 2011, PloS one.

[31]  A. Navarro,et al.  MicroRNAs in Human Embryonic and Cancer Stem Cells , 2010, Yonsei medical journal.

[32]  Zun-Ling Li,et al.  Regulating A549 cells growth by ASO inhibiting miRNA expression , 2010, Molecular and Cellular Biochemistry.

[33]  Liqin Wang,et al.  A Truncated P2X7 Receptor Variant (P2X7-j) Endogenously Expressed in Cervical Cancer Cells Antagonizes the Full-length P2X7 Receptor through Hetero-oligomerization* , 2006, Journal of Biological Chemistry.

[34]  Charles D. Johnson,et al.  Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. , 2007, Cancer research.

[35]  Catalin Vasilescu,et al.  MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis , 2009, PloS one.

[36]  G. Gorodeski P2X7-mediated chemoprevention of epithelial cancers , 2009, Expert opinion on therapeutic targets.

[37]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[38]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[39]  H. Kuo,et al.  c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. , 2008, Molecular biology and evolution.

[40]  C. Mayr,et al.  miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely , 2007, Proceedings of the National Academy of Sciences.